Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

被引：0
|
作者：
Mansour Tobaiqy
Hajer Elkout
机构：
[1] University of Jeddah,Department of Pharmacology, College of Medicine
[2] University of Tripoli,Department of Family and Community Medicine, Medical Faculty
来源：
International Journal of Clinical Pharmacy | 2024年 / 46卷
关键词：
Liraglutide; Obesity; Psychiatric adverse events; Semaglutide; Suicide; Tirzepatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：488 / 495
页数：7
相关论文
共 50 条
  • [1] Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
    Tobaiqy, Mansour
    Elkout, Hajer
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 488 - 495
  • [2] Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database
    Khurana, Atul
    Rabbani, Syed Arman
    El-Tanani, Mohamed
    Arora, Mandeep Kumar
    Sharma, Shrestha
    Dubey, Harikesh
    Aljabali, Alaa A.
    Tambuwala, Murtaza M.
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 30
  • [3] PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
    Gabriella di Mauro
    Alessia Zinzi
    Cristina Scavone
    Annamaria Mascolo
    Mario Gaio
    Liberata Sportiello
    Carmen Ferrajolo
    Concetta Rafaniello
    Francesco Rossi
    Annalisa Capuano
    Drug Safety, 2021, 44 : 337 - 349
  • [4] PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
    di Mauro, Gabriella
    Zinzi, Alessia
    Scavone, Cristina
    Mascolo, Annamaria
    Gaio, Mario
    Sportiello, Liberata
    Ferrajolo, Carmen
    Rafaniello, Concetta
    Rossi, Francesco
    Capuano, Annalisa
    DRUG SAFETY, 2021, 44 (03) : 337 - 349
  • [5] The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Events Reporting System (FAERS) database
    Caruso, I.
    Di Gioia, L.
    Di Molfetta, S.
    Caporusso, M.
    Cignarelli, A.
    Sorice, G.
    Laviola, L.
    Giorgino, F.
    DIABETOLOGIA, 2024, 67 : S360 - S360
  • [6] Adverse drug reactions reports for trastuzumab: an analysis of Brazilian pharmacovigilance database and VigiBase®/WHO and EudraVigilance/EMA
    Barcelos, F.
    Matos, G.
    Costa Lima-Dellamora, E.
    DRUG SAFETY, 2017, 40 (10) : 1006 - 1007
  • [7] Gastrointestinal adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the EudraVigilance and VigiAccess databases
    Rabbani, Syed Arman
    Khurana, Atul
    El-Tanani, Mohamed
    Arora, Mandeep Kumar
    Sharma, Shrestha
    Sridhar, Sathvik B.
    Dubey, Harikesh
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [8] Bisphosphonate-Associated Psychiatric Adverse Events: A Signal from the Italian Pharmacovigilance Database
    Conforti, A.
    Corsano, S.
    Catalano, L.
    Magro, L.
    Donati, M.
    Leone, R.
    DRUG SAFETY, 2010, 33 (10) : 940 - 941
  • [9] Completeness Score of Individual Case Safety Reports in Vietnam National Pharmacovigilance Database
    Nguyen, T. P.
    Trinh, N. T. H.
    Nguyen, A. H.
    Tran, H. N.
    DRUG SAFETY, 2014, 37 (10) : 849 - 850
  • [10] Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
    de Filippis, Renato
    Kane, John M.
    Arzenton, Elena
    Moretti, Ugo
    Raschi, Emanuel
    Trifiro, Gianluca
    Barbui, Corrado
    De Fazio, Pasquale
    Gastaldon, Chiara
    Schoretsanitis, Georgios
    DRUG SAFETY, 2024, 47 (08) : 745 - 757
12345